Michael Ephraim Wechsler MD
Critical Care Medicine, Pleural Disease
Director of Asthma - Dept of Medicine, National Jewish Health
Join to View Full Profile
1400 Jackson St# NationalDenver, CO 80206
Phone+1 303-388-4461
Fax+1 303-270-2206
Dr. Wechsler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General Hospital/BIDMC/Harvard Medical SchoolFellowship, Pulmonary Disease and Critical Care Medicine, 1996 - 2000
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1993 - 1996
McGill University Faculty of MedicineClass of 1993
Certifications & Licensure
CO State Medical License 2012 - 2025
MA State Medical License 1995 - 2018
FL State Medical License 2013 - 2015
American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- American Association of Physicians AAP, 2022
- Elected Member The American Society for Clinical Investigation, 2012
Clinical Trials
- Mepolizumab As a Steroid-sparing Treatment Option in the Churg Strauss Syndrome Start of enrollment: 2007 Sep 01
- Characterization of Placebo Responses in Stable Asthma Start of enrollment: 2005 Jan 01
Publications & Presentations
PubMed
- Eosinophilic granulomatosis with polyangiitis: Patient profiles from a large US allergy practice.Michael E Wechsler, Anna Kovalszki, Jared Silver, Brian Stone, William McCann
The Journal of Allergy and Clinical Immunology. Global. 2025-05-01 - Con: clinical remission in asthma - not yet there.Lauren Eggert, Sarah Rhoads, Michael E Wechsler, Praveen Akuthota
European Respiratory Review. 2025-04-01 - 2 citationsPatient-centred composite scores as tools for assessment of response to biological therapy for paediatric and adult severe asthma.Ekaterina Khaleva, Chris Brightling, Thomas Eiwegger, Alan Altraja, Philippe Bégin
The European Respiratory Journal. 2025-03-01
Journal Articles
- Pulmonary Eosinophilic Granulomatosis with Polyangiitis Has IgG4 Plasma Cells and Immunoregulatory FeaturesZachary M Dong, Michael E Wechsler, Praveen Akuthota, Peter A Merkel, Ulrich Specks, Benjamin Raby, Frederic Clayton, The American Journal of Pathology
- Baseline Patient Factor Impact on the Clinical Efficacy of Benralizumab for Severe AsthmaJames G Zangrilli, Michael E Wechsler, The European Respiratory Journal
- Care Pathways for the Selection of a Biologic in Severe AsthmaMichael E Wechsler, Wanda Phipatanakul, Nicola A Hanania, The European Respiratory Journal
Press Mentions
Novel Therapies for Asthma in the PipelineDecember 2nd, 2024- FDA Approves Benralizumab for Eosinophilic Granulomatosis with PolyangiitisSeptember 19th, 2024
- Benralizumab Now FDA Approved to Treat EGPA VasculitisSeptember 19th, 2024
- Join now to see all
Grant Support
- Anti- IL5 Therapy For Churg-Strauss Syndrome: A Double Blind Randomized, Placebo-National Institute Of Allergy And Infectious Diseases2010
- The Reliability Of The Placebo Effect In AsthmaNational Center For Complementary &Alternative Medicine2006–2007
- Polymorphisms Of Neural NOS And The Asthma PhenotypeNational Heart, Lung, And Blood Institute2001–2005
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
